Search company, investor...

Predict your next investment

Medtronic company logo
Corporation
HEALTHCARE | Medical Equipment & Supplies
medtronic.com

Investments

115

Portfolio Exits

27

Partners & Customers

10

Service Providers

2

About Medtronic

Medtronic (NYSE: MDT) is a healthcare solutions company. It develops technologies, including implantable mechanical devices, drug and biologic delivery devices, and powered and advanced energy surgical instruments. The company was founded in 1949 and is based in Minneapolis, Minnesota.

Headquarters Location

710 Medtronic Parkway

Minneapolis, Minnesota, 55432,

United States

736-514-4000

Want to inform investors similar to Medtronic about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Expert Collections containing Medtronic

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Medtronic in 7 Expert Collections, including Regenerative Medicine.

R

Regenerative Medicine

1,818 items

Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).

C

Conference Exhibitors

5,302 items

D

Diabetes

1,904 items

T

Telehealth

2,856 items

Companies developing, offering, or using electronic and telecommunication technologies to facilitate the delivery of health & wellness services from a distance. *Columns updated as regularly as possible; priority given to companies with the most and/or most recent funding.

M

Medical Devices

4,723 items

https://www.advamed.org/membership-join/membership-directory/ - excludes those without working websites.

H

Health Monitoring & Diagnostics

1,363 items

At-home IVD test developers, at-home sample collection device developers, at-home testing service providers, and all other companies playing in the at-home testing ecosystem. Companies tagged as #AtHomeTestingEcosystem

Latest Medtronic News

Automated CPR Devices Market is expected to grow at approximately 13% CAGR throughout the forecast period of 2021 to 2031

May 27, 2023

Search jobs 27-May-2023 Automated CPR Devices Market is expected to grow at approximately 13% CAGR throughout the forecast period of 2021 to 2031 According to the most recent study report from ESOMAR-certified Future Market Insights (FMI), the Automated CPR Devices Market has been growing significantly as sudden cardiac arrest rates increase globally. According to the study, the worldwide market for automated CPR devices is anticipated to expand at a CAGR of roughly 13% from 2021 to 2031. The market is expected to expand considerably over the next ten years as more coronary and intensive care units turn to automated CPR devices due to their high efficacy. Significant advancements have been made with 3D automated CPR devices, particularly when standard CPR equipment is used in conjunction with torso restraints to provide vertical compression and high-quality resuscitation. Request For Report Sample @  https://www.futuremarketinsights.com/reports/sample/rep-gb-720 Automated CPR devices experienced a surge in demand during the Covid-19 pandemic. COVID-19 infected heart patients were more susceptible to cardiac arrest in comparison with non infected patients. With rapid mutation of virus, the patients were facing higher risk of cardiac arrest. “Rising consumer awareness regarding benefits of CPR devices and increasing adoption in EMT services will amplify sales of automated CPR devices during the forecast period,” says the FMI analyst. Key Takeaways from FMI’s Automated CPR Devices Market Study Presence of modern healthcare infrastructure and high per capita income will bolster demand across the U.S. The U.K is expected to offer growth opportunities as governments and private organizations are working towards spreading awareness regarding dangers of cardiovascular diseases. Rising prevalence of obesity and high blood pressure which are precursor to cardiac arrest will increase automated CPR devices adoption across France. China will offer lucrative opportunities owing to increasing alcohol and tobacco consumption and developing healthcare infrastructure. India is expected to exhibit impressive market growth owing to increase in geriatric population and growing incidence of sudden cardiac arrest in the country. Competitive Landscape: Automated CPR market is highly consolidated owing to presence of regional and global market players. Key market players in automated CPR devices market are focusing towards employing inorganic market strategies to expand their global foothold. Ask from Market Research Expert@  https://www.futuremarketinsights.com/ask-question/rep-gb-720 Inorganic strategies include strategic merger and acquisition and forming an alliance with regional distributors to strengthen their supply chain channels. They are also emphasizing towards faster product approvals, product development and patenting. New market entrants are focusing on new product launches to establish their market presence. For instance, Michigan Instruments launched hand-free automatic CPR device which is light weight, portable and helps in smooth transition from manual CPR to automated compressions. ZOLL Medical Corporation introduced a new automated CPR devices system “Autopulse” which assists EMS personnel in providing high quality chest compressions in cramped spaces and steep down stairwells. Prominent players operating in the automated CPR devices market are SunLife Science Inc., ZOLL Medical Corporation, Michigan Instruments, Physio Control Inc., Brunswick Biomedical Technologies, Zhuhai Kindway Medical Science & Technology Co. Ltd, CPR Medical Devices Inc., and Medtronic Inc. In its latest report, FMI offers an unbiased analysis of the global automated CPR devices market, providing historical data for the period of 2016-2020 and forecast statistics for the period of 2021-2031. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of power source (pneumatically driven CPR devices, battery driven CPR devices, and mechanically actuated and battery driven CPR device), device type (piston devices, load distribution devices, and 3D compression devices) and end user for (Ems, hospitals, ambulances, coronary & intensive care units, cardiac catheterization labs, air med-evac units, and EMT rescue units) across North America, Europe, Latin America, Asia Pacific, and the Middle East and Africa. For more Report Customization, connect with us at@ https://www.futuremarketinsights.com/customization-available/rep-gb-720 Key Segments Covered:

Medtronic Investments

115 Investments

Medtronic has made 115 investments. Their latest investment was in Maribel Health as part of their Series A on March 3, 2023.

CBI Logo

Medtronic Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

3/15/2023

Series A

Maribel Health

$25M

Yes

5

3/15/2023

Series C - II

FIRE1

$25M

No

12

7/13/2022

Corporate Minority

CathWorks

$75M

Yes

6

7/5/2022

Series D

Subscribe to see more

$99M

Subscribe to see more

10

6/1/2022

Series C

Subscribe to see more

Subscribe to see more

10

Date

3/15/2023

3/15/2023

7/13/2022

7/5/2022

6/1/2022

Round

Series A

Series C - II

Corporate Minority

Series D

Series C

Company

Maribel Health

FIRE1

CathWorks

Subscribe to see more

Subscribe to see more

Amount

$25M

$25M

$75M

$99M

New?

Yes

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

5

12

6

10

10

Medtronic Portfolio Exits

27 Portfolio Exits

Medtronic has 27 portfolio exits. Their latest portfolio exit was Orchestra BioMed on January 26, 2023.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

1/26/2023

Reverse Merger

$99M

3

1/17/2023

Acquired

$99M

9

10/6/2021

Acquired - II

$99M

4

2/2/2021

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

8/19/2020

Asset Sale

Subscribe to see more

$99M

Subscribe to see more

10

Date

1/26/2023

1/17/2023

10/6/2021

2/2/2021

8/19/2020

Exit

Reverse Merger

Acquired

Acquired - II

Acquired

Asset Sale

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

3

9

4

10

10

Medtronic Acquisitions

74 Acquisitions

Medtronic acquired 74 companies. Their latest acquisition was EOFlow on May 25, 2023.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

5/25/2023

Other

$99M

$24.67M

Acq - Pending

6

5/13/2022

Series D

$99M

$83.5M

Acq - P2P

4

4/27/2022

$99M

Acquired Unit

2

1/10/2022

Series C

Subscribe to see more

$99M

$99M

Subscribe to see more

10

10/29/2020

Subscribe to see more

$99M

Subscribe to see more

10

Date

5/25/2023

5/13/2022

4/27/2022

1/10/2022

10/29/2020

Investment Stage

Other

Series D

Series C

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Total Funding

$24.67M

$83.5M

$99M

Note

Acq - Pending

Acq - P2P

Acquired Unit

Subscribe to see more

Subscribe to see more

Sources

6

4

2

10

10

Medtronic Partners & Customers

10 Partners and customers

Medtronic has 10 strategic partners and customers. Medtronic recently partnered with Orchestra BioMed on May 5, 2023.

Date

Type

Business Partner

Country

News Snippet

Sources

5/12/2023

Licensor

United States

Orchestra BioMed Reports First Quarter 2023 Financial Results and Provides Business Update

Orchestra BioMed has a strategic collaboration with Medtronic plc , one of the largest medical device companies in the world , for development and commercialization of BackBeat CNT for the treatment of hypertension in pacemaker-indicated patients , and a strategic partnership with Terumo Corporation , a global leader in medical technology , for development and commercialization of Virtue SAB for the treatment of artery disease .

2

5/3/2023

Client

India

AIIMS and Medtronic Partner to Launch New Surgical Robotics Training Center at AIIMS, New Delhi

The training will help impart procedural knowledge skills using surgical robotics among surgeons , fellows , and residents from across the country.Medtronics partnership with AIIMS is a cornerstone of our commitment to make the benefits of RAS available to more patients in India .

1

4/4/2023

Licensor

India

Medtronic and Qure.ai Partner to Advance Stroke Management Using Artificial Intelligence in India

The partnership with Medtronic is another important pillar in our commitment to utilize the power of AI to enhance patient care and bring equitable healthcare to all . ''

5

4/3/2023

Partner

United States

Subscribe to see more

Subscribe to see more

10

3/31/2023

Licensor

United States

Subscribe to see more

Subscribe to see more

10

Date

5/12/2023

5/3/2023

4/4/2023

4/3/2023

3/31/2023

Type

Licensor

Client

Licensor

Partner

Licensor

Business Partner

Country

United States

India

India

United States

United States

News Snippet

Orchestra BioMed Reports First Quarter 2023 Financial Results and Provides Business Update

Orchestra BioMed has a strategic collaboration with Medtronic plc , one of the largest medical device companies in the world , for development and commercialization of BackBeat CNT for the treatment of hypertension in pacemaker-indicated patients , and a strategic partnership with Terumo Corporation , a global leader in medical technology , for development and commercialization of Virtue SAB for the treatment of artery disease .

AIIMS and Medtronic Partner to Launch New Surgical Robotics Training Center at AIIMS, New Delhi

The training will help impart procedural knowledge skills using surgical robotics among surgeons , fellows , and residents from across the country.Medtronics partnership with AIIMS is a cornerstone of our commitment to make the benefits of RAS available to more patients in India .

Medtronic and Qure.ai Partner to Advance Stroke Management Using Artificial Intelligence in India

The partnership with Medtronic is another important pillar in our commitment to utilize the power of AI to enhance patient care and bring equitable healthcare to all . ''

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

2

1

5

10

10

Medtronic Service Providers

2 Service Providers

Medtronic has 2 service provider relationships

Service Provider

Associated Rounds

Provider Type

Service Type

Acq - P2P

Investment Bank

Financial Advisor

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Service Provider

Subscribe to see more

Associated Rounds

Acq - P2P

Subscribe to see more

Provider Type

Investment Bank

Subscribe to see more

Service Type

Financial Advisor

Subscribe to see more

Partnership data by VentureSource

Medtronic Team

107 Team Members

Medtronic has 107 team members, including current Founder, Chief Technology Officer, Daniel C Sigg.

Name

Work History

Title

Status

Daniel C Sigg

Novo Nordisk, and University Hospital Basel

Founder, Chief Technology Officer

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Daniel C Sigg

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Work History

Novo Nordisk, and University Hospital Basel

Title

Founder, Chief Technology Officer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Compare Medtronic to Competitors

Stryker Logo
Stryker

Stryker (NYSE: SYK) develops, manufactures, and markets specialty surgical and medical products worldwide. It offers orthopedic implants, trauma systems, powered surgical instruments, endoscopic systems, and, patient care and handling equipment. It was founded in 1941 and is based in Kalamazoo, Michigan.

A
Advanced Osteotomy Tools

Advanced Osteotomy Tools is reinventing bone surgery. It develops novel digital solutions. It offers laser osteotome for clinical use and uses cold ablation laser combined with robotics, navigation, and smart software. The company was founded in 2010 and is based in Basel, Switzerland.

I
Intuitive Surgical

Intuitive Surgical is a medical equipment manufacturing company. The company manufactures and markets robotic products to improve clinical outcomes for patients through minimally invasive surgery, most notably with the da Vinci Surgical System. It was founded in 1995 and is based in Sunnyvale, California.

SeaSpine Logo
SeaSpine

SeaSpine is a global medical technology company focused on the design, development, and commercialization of surgical solutions for use in spine surgery. Its products include anterior and posterior fixation, access systems, bone graft substitutes, and collagen ceramic matrix. The company was founded in 2002 and is based in Carlsbad, California. In January 2023, SeaSpine was acquired by Orthofix. The terms of the transaction were not disclosed.

Brainlab Logo
Brainlab

Brainlab develops, manufactures and markets software-driven medical technology, enabling access to improved, more efficient, less-invasive patient treatments. Core products revolve around less-invasive image guided surgery technology, more accurate and effective radiation therapy, and integration through planning and collaboration systems that bring patient data and physicians together. Brainlab technology currently powers treatments in the fields of neurosurgery, radiation oncology, orthopedics, ENT, CMF, spine, and trauma.

Diabeloop Logo
Diabeloop

Diabeloop is a medical device company developing an artificial pancreas system that enables the complete automation of insulin delivery and uses information from a continuous blood glucose monitor (CGM) to calculate and deliver the optimal insulin dose to patients in real-time. The device has the potential to provide more accurate regulation of blood-sugar levels in insulin-dependent people with Type 1 diabetes, preventing hypoglycemic and hyperglycemic events and other long-term complications that may arise from diabetes. Diabeloop was founded in 2015 and is based in Grenoble, France.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.